Drugs / 11C-L-deprenyl-D2
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01701089 Background | Sep 2012 → May 2013 | Alzheimer disease 5 | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-L-deprenyl-D2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01701089 ↗ |
| Route | Intravenous | “Intravenous injection of 11C-L-deprenyl-D2 before positron emission tomography (PET); up to 3 injections in total” NCT01701089 ↗ |